Pirfenidone: a novel antifibrotic agent with implications for the treatment of obliterative bronchiolitis
Open Access
- 1 August 1998
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 30 (5) , 1910-1911
- https://doi.org/10.1016/s0041-1345(98)00478-3
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Pirfenidone Attenuates Bleomycin-Induced Changes in Pulmonary Functions in HamstersExperimental Biology and Medicine, 1997
- Pirfenidone diminishes cyclophosphamide-induced lung fibrosis in miceToxicology Letters, 1997
- Risk factors for chronic rejection in heart and lungs – Why do hearts and lungs rot?Clinical Transplantation, 1994
- Characterization of the Cellular Reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): Subcellular Localization, Substrate Dependence, and Involvement of Mitochondrial Electron Transport in MTT ReductionArchives of Biochemistry and Biophysics, 1993